n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane has been researched along with Hyperamylasemia in 2 studies
*Hyperamylasemia: A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adham, M; Andersson, R; Bannone, E; Barreto, SG; Bassi, C; Besselink, MG; Bockhorn, M; Büchler, MW; Busch, ORC; Conlon, K; Connor, S; Del Chiaro, M; Dervenis, C; Falconi, M; Fingerhut, A; Friess, H; Fusai, GK; Gianotti, L; Hackert, T; Halloran, CM; Hilal, MA; Izbicki, JR; Lillemoe, KD; Loos, M; Marchegiani, G; Miao, Y; Montorsi, M; Neoptolemos, JP; Oláh, A; Padbury, R; Passas, I; Probst, P; Salvia, R; Sarr, M; Schulick, RD; Serrablo, A; Shrikhande, SV; Siriwardena, AK; Strobel, O; Takaori, K; Vashist, YK; Vollmer, CM; Werner, J; Wolfgang, CL; Yeo, CJ; Zerbi, A; Zyromski, NJ | 1 |
| Distler, M; Kahlert, C; Missel, L; Oehme, F; Radulova-Mauersberger, O; Weitz, J; Welsch, T | 1 |
2 other study(ies) available for n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane and Hyperamylasemia
| Article | Year |
|---|---|
Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading From the International Study Group for Pancreatic Surgery (ISGPS).
Topics: Acute Disease; Humans; Hyperamylasemia; Pancreatectomy; Pancreatic Fistula; Pancreaticoduodenectomy; Pancreatitis; Postoperative Complications; Propylamines | 2022 |
Analysis of predictors for postoperative complications after pancreatectomy--what is new after establishing the definition of postpancreatectomy acute pancreatitis (PPAP)?
Topics: Acute Disease; Humans; Hyperamylasemia; Pancreatectomy; Pancreatic Fistula; Pancreaticoduodenectomy; Pancreatitis; Postoperative Complications; Retrospective Studies; Risk Factors | 2023 |